首页> 外文期刊>Hearing Research: An International Journal >Cannabinoids, cannabinoid receptors and tinnitus
【24h】

Cannabinoids, cannabinoid receptors and tinnitus

机译:大麻素,大麻素受体和耳鸣

获取原文
获取原文并翻译 | 示例
           

摘要

One hypothesis suggests that tinnitus is a form of sensory epilepsy, arising partly from neuronal hyperactivity in auditory regions of the brain such as the cochlear nucleus and inferior colliculus. Although there is currently no effective drug treatment for tinnitus, anti-epileptic drugs are used in some cases as a potential treatment option. There is increasing evidence to suggest that cannabinoid drugs, i.e. cannabinoid receptor agonists, can also have anti-epileptic effects, at least in some cases and in some parts of the brain. It has been reported that cannabinoid CBI receptors and the endogenous cannabinoid, 2-arachidonylglycerol (2-AG), are expressed in the cochlear nucleus and that they are involved in the regulation of plasticity. This review explores the question of whether cannabinoid receptor agonists are likely to be pro- or anti-epileptic in the cochlear nucleus and therefore whether cannabinoids and Cannabis itself are likely to make tinnitus better or worse. (C) 2015 Elsevier B.V. All rights reserved.
机译:一种假设表明,耳鸣是一种感觉性癫痫,部分是由于大脑听觉区域(如耳蜗核和下丘脑)的神经元过度活跃引起的。尽管目前尚无有效的耳鸣药物治疗方法,但在某些情况下使用抗癫痫药作为潜在的治疗选择。越来越多的证据表明,至少在某些情况下和在大脑的某些部位,大麻素药物(即大麻素受体激动剂)也可能具有抗癫痫作用。据报道,大麻素CBI受体和内源性大麻素2-花生四烯酸甘油酯(2-AG)在耳蜗核中表达,它们参与可塑性的调节。这篇综述探讨了大麻素受体激动剂在耳蜗核中可能是促癫痫药还是抗癫痫药的问题,因此大麻素和大麻本身是否可能使耳鸣变得更好或更坏。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号